Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
NCT00705588
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Tadalafil
DRUG:
Vardenafil
Sponsor
Rabin Medical Center